Related Experiment Video
Updated: Jun 15, 2025

09:30
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
1.3K
Structural visualization of inhibitor binding in prolyl oligopeptidase
Katarzyna Walczewska-Szewc1, Jakub Rydzewski1
1Institute of Physics, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University in Toruń, ul. Grudziądzka 5, 87-100 Toruń, Poland.
Biophysics Reviews
|August 26, 2024
Summary
Understanding how drug molecules bind to proteins like prolyl oligopeptidase (PREP) is key for developing new therapies. This study visualizes how small changes in inhibitors affect PREP
Area of Science:
- Biophysics
- Computational Chemistry
- Neuroscience
Background:
- Protein-ligand interactions are vital for drug development but challenging to study.
- Molecular dynamics (MD) simulations often require enhanced sampling for rare events like ligand binding.
- Prolyl oligopeptidase (PREP) is implicated in neurodegenerative diseases and protein aggregation.
Purpose of the Study:
- To investigate the diverse ligand binding pathways in PREP.
- To understand how subtle inhibitor modifications impact PREP dynamics and binding.
- To provide visual insights into ligand transport mechanisms for therapeutic targeting.
Main Methods:
- Enhanced sampling molecular dynamics (MD) simulations.
- Visual analysis of ligand pathways through protein transient tunnels.
- Computational modeling of protein-ligand interactions.
Main Results:
- Ligand binding pathways in PREP are sensitive to small changes in inhibitor structure.
- Enhanced sampling MD successfully visualized complex ligand transport routes.
- The study identified distinct binding mechanisms influenced by inhibitor properties.
Conclusions:
- Visualizing ligand binding pathways is crucial for understanding PREP's role in neurodegeneration.
- Subtle inhibitor modifications can significantly alter therapeutic potential.
- This work aids in designing more effective PREP inhibitors for neurodegenerative diseases.
Related Concept Videos
Enzymes
81.2K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.2K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Enzyme Inhibition
78.1K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.1K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K

